This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

7 Companies That Keep on Growing

Mylan Labs

Mylan Labs (MYL - Get Report), a provider of generic drugs, has been one of the key beneficiaries of the ongoing stream of big pharma drugs that lose patent protection. As more drugs have moved off-patent, Mylan's opportunities have expanded. And as the company doesn't need to spend a lot on R&D every year, it has become a veritable cash cow: Mylan has generated a collective $900 million in free cash flow over the last two years.

The road ahead looks bright as well, thanks to another wave of major drugs soon to go off-patent. This will never be a high-growth stock, but 10% annual profit growth looks quite achievable.

And that outlook doesn't require a robust economy. Shares are actually below where they were back in late 2003, even though Mylan's sales base is much larger. Back then, this stock made a run at the $30 mark, and from a recent $23, could do so again in the next year or two.

As of the most recently reported quarter, Mylan is one of John Paulson's top holdings.

To see these stocks in action, check out the Perpetual Growers portfolio.


Follow Stockpickr on Twitter and become a fan on Facebook.
Stockpickr is a wholly owned subsidiary of

At the time of publication, author had no positions in stocks mentioned.
8 of 8

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
ABT $38.84 -0.14%
CSCO $27.38 -0.40%
GILD $89.01 0.91%
KSS $45.04 1.70%
MYL $42.74 2.50%


Chart of I:DJI
DOW 17,891.16 +117.52 0.66%
S&P 500 2,081.39 +16.09 0.78%
NASDAQ 4,817.5940 +42.2360 0.88%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs